285 related articles for article (PubMed ID: 20831495)
1. Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques.
Vogelius IS; Westerly DC; Cannon GM; Bentzen SM
Acta Oncol; 2010 Oct; 49(7):1052-7. PubMed ID: 20831495
[TBL] [Abstract][Full Text] [Related]
2. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
3. Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer.
Vogelius IR; Westerly DC; Aznar MC; Cannon GM; Korreman SS; Mackie TR; Mehta MP; Bentzen SM
Acta Oncol; 2011 Aug; 50(6):772-6. PubMed ID: 21767173
[TBL] [Abstract][Full Text] [Related]
4. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC.
Cattaneo GM; Dell'oca I; Broggi S; Fiorino C; Perna L; Pasetti M; Sangalli G; di Muzio N; Fazio F; Calandrino R
Radiother Oncol; 2008 Sep; 88(3):310-8. PubMed ID: 18692266
[TBL] [Abstract][Full Text] [Related]
5. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
[TBL] [Abstract][Full Text] [Related]
6. Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.
Alharbi M; Janssen S; Golpon H; Bremer M; Henkenberens C
Radiat Oncol; 2017 Nov; 12(1):165. PubMed ID: 29096667
[TBL] [Abstract][Full Text] [Related]
7. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
[TBL] [Abstract][Full Text] [Related]
8. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; PĂ©rol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
9. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
[TBL] [Abstract][Full Text] [Related]
10. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
van Baardwijk A; Bosmans G; Bentzen SM; Boersma L; Dekker A; Wanders R; Wouters BG; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1103-10. PubMed ID: 18258382
[TBL] [Abstract][Full Text] [Related]
11. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
Willner J; Jost A; Baier K; Flentje M
Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping.
Vogelius IS; Westerly DC; Cannon GM; Mackie TR; Mehta MP; Sugie C; Bentzen SM
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):893-9. PubMed ID: 21477946
[TBL] [Abstract][Full Text] [Related]
13. Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks.
Komisopoulos G; Mavroidis P; Rodriguez S; Stathakis S; Papanikolaou N; Nikiforidis GC; Sakellaropoulos GC
Med Dosim; 2014; 39(4):337-47. PubMed ID: 25168596
[TBL] [Abstract][Full Text] [Related]
14. Helical tomotherapy for solitary lung tumor: feasibility study and dosimetric evaluation of treatment plans.
Tomita N; Kodaira T; Matsuo M; Furutani K; Tachibana H; Daimon T; Shimizu H
Technol Cancer Res Treat; 2010 Aug; 9(4):407-15. PubMed ID: 20626206
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D conformal radiation modalities in lung cancer radiotherapy.
Mavroidis P; Shi C; Plataniotis GA; Delichas MG; Ferreira BC; Rodriguez S; Lind BK; Papanikolaou N
Br J Radiol; 2011 Feb; 84(998):161-72. PubMed ID: 20858664
[TBL] [Abstract][Full Text] [Related]
16. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
Rosenzweig KE; Mychalczak B; Fuks Z; Hanley J; Burman C; Ling CC; Armstrong J; Ginsberg R; Kris MG; Raben A; Leibel S
Cancer J; 2000; 6(2):82-7. PubMed ID: 11069224
[TBL] [Abstract][Full Text] [Related]
17. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
18. Estimation of radiation-induced secondary cancer risks for early-stage non-small cell lung cancer patients after stereotactic body radiation therapy.
Han C; Schultheiss TE; Wong JYC
Pract Radiat Oncol; 2017; 7(3):e185-e194. PubMed ID: 28089479
[TBL] [Abstract][Full Text] [Related]
19. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
20. Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancer.
Manon RR; Jaradat H; Patel R; Zhang T; Fenwick J; Tome W; Fowler J; Paliwal B; Soisson E; Yuan Z; Mehta M
Clin Lung Cancer; 2005 Sep; 7(2):107-13. PubMed ID: 16179097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]